HR830-119

Introduced

To amend the Controlled Substances Act with respect to fentanyl-related substances, and for other purposes.

119th Congress Introduced Jan 31, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill requires permanent classification of fentanyl-related substances as Schedule I controlled substances under the CSA, requires weight-based penalty thresholds for domestic fentanyl offenses with mandatory minimums, and requires weight-based penalty thresholds for fentanyl import and export offenses. It relies on compliance mandates, exemptions, definition changes, and reporting requirements. The main policy areas are Criminal Justice, Science & Space, Healthcare, and Education.

Who Benefits and How

Defendants convicted of offenses involving subsequently removed fentanyl substances could face reduced risk, Academic and clinical researchers studying fentanyl-related substances could face lower compliance burdens, and Research institutions and universities could face fewer barriers.

Who Bears the Burden and How

International fentanyl traffickers and importers could face increased risk, Illicit fentanyl manufacturers and distributors could face higher barriers, and Drug offenders possessing 400g+ fentanyl mixtures could face increased risk.

Key Provisions

  • Requires permanent classification of fentanyl-related substances as Schedule I controlled substances under the CSA.
  • Requires weight-based penalty thresholds for domestic fentanyl offenses with mandatory minimums.
  • Requires weight-based penalty thresholds for fentanyl import and export offenses.
  • Exempts scientific review pathway for removing individual fentanyl-related substances from Schedule I when abuse potential is below Schedule V.
  • Exempts retroactive sentencing relief for defendants convicted of offenses involving fentanyl-related substances subsequently removed from Schedule I.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill requires permanent classification of fentanyl-related substances as Schedule I controlled substances under the CSA, requires weight-based penalty thresholds for domestic fentanyl offenses with mandatory minimums, and requires weight-based penalty thresholds for fentanyl import and export offenses.

Key Policy Areas

Criminal Justice, Science & Space, Healthcare, Education

Primary Purpose

The bill requires permanent classification of fentanyl-related substances as Schedule I controlled substances under the CSA, requires weight-based penalty thresholds for domestic fentanyl offenses with mandatory minimums, and requires weight-based penalty thresholds for fentanyl import and export offenses.

Policy Domains

Criminal Justice Science & Space Healthcare Education

Whole bill

Identified Gains
  • Defendants convicted of offenses involving subsequently removed fentanyl substances
  • Academic and clinical researchers studying fentanyl-related substances
  • Research institutions and universities
  • Pharmaceutical companies developing fentanyl-derived therapeutics
  • Law enforcement agencies
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Law enforcement agencies:
Research institutions and universities:
Pharmaceutical companies developing fentanyl-derived therapeutics:
Academic and clinical researchers studying fentanyl-related substances:
Defendants convicted of offenses involving subsequently removed fentanyl substances:
Identified Costs
  • International fentanyl traffickers and importers
  • Illicit fentanyl manufacturers and distributors
  • Drug offenders possessing 400g+ fentanyl mixtures
  • Pharmaceutical researchers studying fentanyl analogues
  • Government Accountability Office
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Government Accountability Office:
Illicit fentanyl manufacturers and distributors:
International fentanyl traffickers and importers:
Drug offenders possessing 400g+ fentanyl mixtures:
Pharmaceutical researchers studying fentanyl analogues:

Legislative Progress

Introduced
Introduced Committee Passed
Jan 31, 2025

Mr. Pappas (for himself, Ms. Salazar, and Mr. Newhouse) introduced …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Law Enforcement
5 mentions across 4 clauses
+4 positive -1 negative

Customs and Border Protection, Defendants convicted of offenses involving subsequently removed fentanyl substances, Drug offenders possessing 400g+ fentanyl mixtures

Positive-direction: Customs and Border Protection, Defendants convicted of offenses involving subsequently removed fentanyl substances, Federal prosecutors, Law enforcement agencies

Negative-direction: Drug offenders possessing 400g+ fentanyl mixtures

Government
4 mentions across 3 clauses
+1 positive -3 negative

Congressional oversight committees, Department of Justice, Government Accountability Office

Positive-direction: Congressional oversight committees

Negative-direction: Department of Justice, Government Accountability Office, Secretary of Health and Human Services

Illegal Activities
2 mentions across 2 clauses
-2 negative

Illicit fentanyl manufacturers and distributors, International fentanyl traffickers and importers

Research & Science
2 mentions across 2 clauses
+1 positive -1 negative

Academic and clinical researchers studying fentanyl-related substances, Pharmaceutical researchers studying fentanyl analogues

Positive-direction: Academic and clinical researchers studying fentanyl-related substances

Negative-direction: Pharmaceutical researchers studying fentanyl analogues

Pharmaceuticals
2 mentions across 2 clauses
+1 positive -1 negative

Pharmaceutical companies developing fentanyl-derived therapeutics, Regulated entities affected by fentanyl scheduling

Positive-direction: Pharmaceutical companies developing fentanyl-derived therapeutics

Negative-direction: Regulated entities affected by fentanyl scheduling

Judiciary
1 mention across 1 clause
-1 negative

Federal courts

Education
1 mention across 1 clause
+1 positive

Research institutions and universities

8/9
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Criminal Justice Science & Space Healthcare Education

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology